Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Cancer och onkologi
Originalspråkengelska
Sidor (från-till)119-128
TidskriftMolecular Oncology
Volym8
Utgivningsnummer1
StatusPublished - 2014
PublikationskategoriForskning
Peer review utfördJa

Nedladdningar

Ingen tillgänglig data

Relaterad forskningsoutput

Siker Kimbung, 2014, Oncology, MV. 152 s.

Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

Visa alla (1)